[ad_1]
The new readjustment of individual and family health plans comes into effect in May 2019. The National Supplementary Health Agency (ANS) has modified the calculation rule to define the adjustment index in the plans. .
The measure was published Thursday (20) in the "Official Journal of the Union".
The agency said the last 10% adjustment remained valid until April 2019. The agency would continue to disclose a maximum rate
The difference between the final index readjustment, however, was unclear, both for industry representatives and for consumer protection agencies, who are still waiting for explanations on the calculation. The IRPI (Individual Scheme Adjustment Index), the main component of which is the change in operator expenditure with the badistance of the beneficiaries, applies to contracts concluded after 1 January 1999, when the Scheme Law
According to the NLS, this rule "will more accurately reflect the costs of health", in addition to balancing the final amount paid by the recipient. The annual adjustment can be applied only from the date of the anniversary of the contract
SECTOR REGULATORY AGENCY COBRA CLAREZA
Abramge (Brazilian Association of Health Plans) recalled that "the policy of readjustment of individual and family plans" "
According to the entity, the new rule" does not equal the imbalance, but may constitute a transitional model offering greater transparency and security for the health market. Already, Sandro Leal, Regulatory Director of Fenasaúde (National Federation of Public Health), acknowledged that this body had progressed compared to the latest proposals, and said that "there is still a lack of clarity "In the presentation of the standard, which allows to predict the impact of the measurement.
The Procon-SP supervisor, Maria Feitosa Lacerda, also criticizes the lack of clarity." A public hearing, the need for a simulation of the calculation. "Idec (Brazilian Institute of Consumer Protection) lamented that the agency published the new methodology without presenting the simulations.
ANS justified the report, it should be noted that "it performed all the tests necessary to validate the methodology, but does not consider it appropriate to disclose figures that could generate expectations and not be able to be made ". [196] 59011]
[ad_2]
Source link
